Changing landscape of superficial and invasive mycoses

1:15 PM • 2397 • Non-dermatophyte filamentous fungal isolation in nail samples: results from 5 years of cultures > S. Sara GÓMEZ DE FRUTOS (Madrid) 1:20 PM • 2184 • COVID-19-associated pulmonary aspergillosis: a multi-centre, observational cohort study involving 823 patients > N. Nico JANSSEN (Nijmegen) 1:25 PM • 2664 • Gastrointestinal mucormycosis: analysis of 55 cases from the FungiScope® registry > E. Ertan SAL (Cologne) 1:30 PM • 1790 • Cutaneous mucormycosis: analysis of 70 cases from a global registry (www.zygomyco.net) > A. Anna SKIADA (Athens) 1:35 PM • 1827 • Epidemiology of candidaemia in Swiss tertiary care hospitals: a 15-year survey, 2004 to 2018 > K-M. Kai-Manuel ADAM (Basel) 1:40 PM • 1368 • <em>Candida glabrata</em> single- and multidrug-resistance: a five-year analysis of clinical samples from German healthcare facilities > A. Alexander Maximilian ALDEJOHANN (Würzburg) 1:45 PM • 1875 • <em>In vitro</em> antifungal activity of manogepix and registered antifungal agents against South African <em>Candida auris </em>isolates from bloodstream infections > T. Tsidiso Gugu MAPHANGA (Johannesburg) 1:50 PM • 1764 • Azole resistance in <em>Aspergillus fumigatus: </em>the first 2-year data from the Danish nationwide surveillance study > M. Malene RISUM (Copenhagen) 1:55 PM • 2185 • EUCAST susceptibility and squalene epoxidase sequencing of Danish <em>Trichophyton</em> <em>rubrum </em>and <em>Trichophyton interdigitale </em>isolates 2019-2020 suggest worrisome levels of terbinafine resistance. > K. Karen Marie ASTVAD (Valby) 2:00 PM • INT85 • Q&A/Discussion